Diagnostic value of soluble CD14 subtype (sCD14-ST) presepsin for the postmortem diagnosis of sepsis-related fatalities

International Journal of Legal Medicine

Volumn 127, Issue 4, 2013, Pages 799-808

  Palmiere, Cristian ^a   Mussap, Michele ^b   Bardy, Daniel ^c   Cibecchini, Francesco ^b   Mangin, Patrice ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIVERSITY OF GENOA   (Italy)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Postmortem biochemistry; Presepsin; Procalcitonin; Sepsis; Soluble CD14 subtype

Indexed keywords

BIOLOGICAL MARKER; CALCITONIN; CD14 ANTIGEN; PROCALCITONIN; PROTEIN PRECURSOR;

ADOLESCENT; ADULT; AGED; CASE CONTROL STUDY; CHEMISTRY; FEMALE; FORENSIC PATHOLOGY; HUMAN; INFANT; LUMINESCENCE; MALE; MIDDLE AGED; PERICARDIUM; POSTMORTEM CHANGE; SENSITIVITY AND SPECIFICITY; SEPSIS; VERY ELDERLY; ARTICLE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD14; BIOLOGICAL MARKERS; CALCITONIN; CASE-CONTROL STUDIES; FEMALE; FORENSIC PATHOLOGY; HUMANS; INFANT; LUMINESCENT MEASUREMENTS; MALE; MIDDLE AGED; PERICARDIUM; POSTMORTEM CHANGES; PROTEIN PRECURSORS; SENSITIVITY AND SPECIFICITY; SEPSIS;

EID: 84879884785     PISSN: 09379827     EISSN: 14371596     Source Type: Journal    
DOI: 10.1007/s00414-012-0804-5     Document Type: Article

References (51)

1. Gaïni A, Koldkjaer OG, Møller HJ, Pedersen C, Pedersen SS (2007) Comparison of high-mobility group-box 1 protein, lipopolysaccharide- binding protein and procalcitonin in severe community-acquired infections and bacteraemia: A prospective study. Crit Care 11(4):R76. doi: 10.1186/cc5967
2. Schrag B, Iglesias K, Mangin P, Palmiere C (2012) Procalcitonin and C-reactive protein in pericardial fluid for postmortem diagnosis of sepsis. Int J Leg Med 126(4):567-72
3. Porcel JM, Vives M, Cao G, Bielsa S, Ruiz-González A, Martínez-Iribarren A, Esquerda A (2009) Biomarkers of infection for the differential diagnosis of pleural effusions. Eur Respir J 34(6):1383-9
4. Endo S, Suzuki Y, Takahashi G, Shozushima T, Ishikura H, Murai A, Nishida T, Irie Y, Miura M, Iguchi H, Fukui Y, Tanaka K, Nojima T, Okamura Y (2012) Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study. J Infect Chemother. doi: 10.1007/s10156-012-0435-2
5. Palmiere C, Mangin P (2012) Postmortem chemistry update part II. Int J Leg Med 126(2):199-215
6. Schrag B, Roux-Lombard P, Schneiter D, Vaucher P, Mangin P, Palmiere C (2012) Evaluation of C-reactive protein, procalcitonin, tumor necrosis factor alpha, interleukin-6, and interleukin-8 as diagnostic parameters in sepsis-related fatalities. Int J Legal Med 126(4):505-12
7. Herrmann W, Ecker D, Quast S, Klieden M, Rose S, Marzi I (2000) Comparison of procalcitonin, sCD14 and interleukin-6 values in septic patients. Clin Chem Lab Med 38(1):41-6
8. Eberhard OK, Haubitz M, Brunkhorst FM, Kliem V, Koch KM, Brunkhorst R (1997) Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection. Arthritis Rheum 40(7):1250-6
9. Lindahl B, Toss H, Siegbahn A, Venge P, Wallentin L (2000) Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during instability in coronary artery disease. N Engl J Med 343(16):1139-47
10. Reinhart K, Meisner M, Brinkhorst FM (2006) Markers for sepsis diagnosis: What is useful? Crit Care Clin 22(6):503-19
11. Tong HS, Liu YS, Wen Q, Tang YQ, Yuan FF, Su L (2012) Serum procalcitonin predicting mortality in exertional heatstroke. Emerg Med J 29(2):113-7
12. Hausfater P, Hurtado M, Pease S, Juillien G, Lvovschi VE, Salehabadi S, Lidove O, Wollf M, Bernard M, Chollet-Martin S, Riou B (2008) Is procalcitonine a marker of critical illness in heatstroke? Intensive Care Med 34(8):1377-83
13. Nylén ES, Al Arifi A, Becker KL, Snider RH Jr, Alzeer A (1997) Effect of classic heatstroke on serum procalcitonin. Crit Care Med 25(8):1362-5
14. Balci C, Sivaci R, Akbulut G, Karabekir HS (2009) Procalcitonin levels as an early marker in patients with multiple trauma under intensive care. J Int Med Res 37(6):1709-17
15. Maier M, Wutzler S, Lehnert M, Szermutzky M, Wyen H, Bingold T, Henrich D, Walcher F, Marzi I (2009) Serum procalcitonin levels in patients with multiple injuries including visceral trauma. J Trauma 66(1):243-9
16. Mussap M, Degrandi R, Cataldi L, Fanos V, Plebani M (2007) Biochemical markers for the early assessment of neonatal sepsis: The role of procalcitonin. J Chemother 19(Suppl 2):35-8
17. Mussap M, Noto A, Fravega M, Fanos V (2011) Soluble CD14 subtype presepsin (sCD14-ST) and lipopolysaccharide binding protein (LBP) in neonatal sepsis: New clinical and analytical perspectives for two old biomarkers. J Matern Fetal Neonatal Med 24(Suppl 2):12-4
18. Bas S, Gauthier BR, Spenato U, Stingelin S, Gabay C (2004) CD14 is an acute-phase protein. J Immunol 172(7):4470-9
19. Yaegashi Y, Shirakawa K, Sato N, Suzuki Y, Kojika M, Imai S, Takahashi G, Miyata M, Furusako S, Endo S (2005) Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis. J Infect Chemother 11(5):234-8
20. Obata K, Segawa O, Yakabe M, Ishida Y, Kuroita T, Ikeda K, Kawakami B, Kawamura Y, Yohda M, Matsunaga T, Tajima H (2001) Development of a novel method for operating magnetic particles, Magtration Technology, and its use for automating nucleic acid purification. J Biosci Bioeng 91(5):500-3
21. Okamura Y, Yokoi H (2011) Development of a point-of-care assay system for measurement of presepsin (sCD14-ST). Clin Chim Acta 412(23-24):2157-61
22. NCCLS. Protocols for determination of limits of detection and limits of quantitation; approved guideline. NCCLS document 2004 EP17-A [ISBN 1-56238-551-8]. Nccls, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898 USA, 2004.
23. Pavnik-Arnol M, Hojker S, Derganc M (2007) Lypopolysaccharide-binding protein, lipopolysaccharide, and soluble CD14 in sepsis of critically ill neonates and children. Intensive Care Med 33(6):1025-32
24. Chalupa P, Beran O, Herwald H, Kaspříková N, Holub M (2011) Evaluation of potential biomarkers for the discrimination of bacterial and viral infections. Infection 39(5):411-7
25. Tsokos M (2007) Postmortem diagnosis of sepsis. Forensic Sci Int 165(2-3):155-64
26. Tsokos M, Reichelt U, Nierhaus A, Püschel K (2001) Serum procalcitonin (PCT): A valuable biochemical parameter for the postmortem diagnosis of sepsis. Int J Legal Med 114(4-5):237-43
27. Tsokos M, Reichelt U, Jung R, Nierhaus A, Püschel K (2001) Interleukin-6 and C-reactive protein serum levels in sepsis-related fatalities during the early postmortem period. Forensic Sci Int 119(1):47-56
28. Tsokos M, Fehlauer F, Püschel K (2000) Immunohistochemical expression of E-selectin in sepsis-induced lung injury. Int J Legal Med 113(6):338-42
29. Tsokos M, Fehlauer F (2001) Postmortem markers of sepsis: An immunohistochemical study using VLA-4 (CD49d/CD29) and ICAM-1 (CD54) for the detection of sepsis-induced lung injury. Int J Legal Med 114:291-94
30. Reichelt U, Jung R, Nierhaus A, Tsokos M (2005) Serial monitoring of interleukin-1b, soluble interleukin-2 receptor and lipopolysaccharide binding protein levels after death. A comparative evaluation of potential postmortem markers of sepsis. Int J Legal Med 119(2):80-87
31. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC (1990) CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249(4975):1431-3
32. Krüger C, Schütt C, Obertacke U, Joka T, Müller FE, Knöller J, Köller M, König W, Schönfeld W (1991) Serum CD14 levels in polytraumatized and severely burned patients. Clin Exp Immunol 85(2):297-301
33. Jabara HH, Vercelli D (1994) Engagement of CD14 on monocytes inhibits the synthesis of human Igs, including IgE. J Immunol 153(3):972-8
34. Bussolati B, David S, Cambi V, Tobias PS, Camussi G (2002) Urinary soluble CD14 mediates human proximal tubular epithelial cell injury induced by LPS. Int J Mol Med 10(4):441-9
35. Berner R, Fürll B, Stelter F, Dröse J, Müller HP, Schütt C (2002) Elevated levels of lipopolysaccharide-binding protein and soluble CD14 in plasma in neonatal early-onset sepsis. Clin Diagn Lab Immunol 9(2):440-5
36. Aalto H, Takala A, Kautiainen H, Siitonen S, Repo H (2007) Monocyte CD14 and soluble CD14 in predicting mortality of patients with severe community acquired infection. Scand J Infect Dis 39(6-7):596-603
37. Takeshita S, Nakatani K, Tsujimoto H, Kawamura Y, Kawase H, Sekine I (2000) Increased levels of circulating soluble CD14 in Kawasaki disease. Clin Exp Immunol 119(2):376-81
38. Wüthrich B, Kägi MK, Joller-Jemelka H (1992) Soluble CD14 but not interleukin-6 is a new marker for clinical activity in atopic dermatitis. Arch Dermatol Res 284(6):339-42
39. Oesterreicher C, Pfeffel F, Petermann D, Müller C (1995) Increased in vitro production and serum levels of the soluble lipopolysaccharide receptor sCD14 in liver disease. J Hepatol 23(4):396-402
40. Horneff G, Sack U, Kalden JR, Emmrich F, Burmester GR (1993) Reduction of monocyte-macrophage activation markers upon anti-CD4 treatment. Decreased levels of IL-1, IL-6, neopterin and soluble CD14 in patients with rheumatoid arthritis. Clin Exp Immunol 91(2):207-13
41. Yu S, Nakashima N, Xu BH, Matsuda T, Izumihara A, Sunahara N, Nakamura T, Tsukano M, Matsuyama T (1998) Pathological significance of elevated soluble CD14 production in rheumatoid arthritis: In the presence of soluble CD14, lipopolysaccharides at low concentrations activate RA synovial fibroblasts. Rheumatol Int 17(6):237-43
42. Egerer K, Feist E, Rohr U, Pruss A, Burmester GR, Dörner T (2000) Increased serum soluble CD14, ICAM-1 and E-selectin correlate with disease activity and prognosis in systemic lupus erythematosus. Lupus 9(8):614-21
43. Nockher WA, Wigand R, Schoeppe W, Scherberich JE (1994) Elevated levels of soluble CD14 in serum of patients with systemic lupus erythematosus. Clin Exp Immunol 96(1):15-9
44. Gebhard F, Rösch M, Helm M, Strecker W, Buttenschön K, Kinzl L, Bock KH, Brückner UB (1997) Is the activity of soluble CD14 enhanced following major trauma? Arch Surg 132(10):1116-20
45. Carrillo EH, Gordon L, Goode E, Davis E, Polk HC Jr (2001) Early elevation of soluble CD14 may help identify trauma patients at high risk for infection. J Trauma 50(5):810-6
46. Landmann R, Zimmerli W, Sansano S, Link S, Hahn A, Glauser MP, Calandra T (1995) Increased circulating soluble CD14 is associated with high mortality in gram-negative septic shock. J Infect Dis 171(3):639-44
47. Landmann R, Reber AM, Sansano S, Zimmerli W (1996) Function of soluble CD14 in serum from patients with septic shock. J Infect Dis 173(3):661-8
48. Blanco A, Solis G, Arranz E, Coto GD, Ramos A, Telleria J (1996) Serum levels of CD14 in neonatal sepsis by Gram-positive and Gram-negative bacteria. Acta Paediatr 85(6):728-32
49. Kitchens RL, Thompson PA (2003) Impact of sepsis-induced changes in plasma on LPS interactions with monocytes and plasma lipoproteins: Roles of soluble CD14, LBP, and acute phase lipoproteins. J Endotoxin Res 9(2):113-8
50. Shozushima T, Takahashi G, Matsumoto N, Kojika M, Okamura Y, Endo S (2011) Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome. J Infect Chemother 17(6):764-9
51. Maeda H, Zhu BL, Bessho Y, Ishikawa T, Quan L, Michiue T, Zhao D, Li DR, Komatsu A (2008) Postmortem serum nitrogen compounds and C-reactive protein levels with special regard to investigation of fatal hyperthermia. Forensic Sci Med Pathol 4(3):175-80